|
C16ORF80 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.43880000000618E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.059410E-03 |
| Normal-vs-Stage2 |
1.902770E-01 |
| Normal-vs-Stage3 |
1.181730E-02 |
| Normal-vs-Stage4 |
3.465000E-01 |
| Stage1-vs-Stage2 |
4.091400E-01 |
| Stage1-vs-Stage3 |
3.455800E-01 |
| Stage1-vs-Stage4 |
6.784600E-01 |
| Stage2-vs-Stage3 |
1.784990E-01 |
| Stage2-vs-Stage4 |
9.565600E-01 |
| Stage3-vs-Stage4 |
3.637000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.628200E-04 |
| Normal-vs-AfricanAmerican |
6.122000E-03 |
| Normal-vs-Asian |
1.650780E-01 |
| Caucasian-vs-AfricanAmerican |
5.921000E-01 |
| Caucasian-vs-Asian |
2.285600E-01 |
| AfricanAmerican-vs-Asian |
3.468600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.235790E-04 |
| Normal-vs-Female |
3.739100E-03 |
| Male-vs-Female |
9.659600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.638000E-01 |
| Normal-vs-Extreme_Weight |
5.179200E-03 |
| Normal-vs-Obese |
1.464640E-03 |
| Normal-vs-Extreme_Obese |
6.765000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.255200E-01 |
| Normal_Weight-vs-Obese |
5.396500E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.975800E-01 |
| Extreme_Weight-vs-Obese |
7.690400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.822200E-01 |
| Obese-vs-Extreme_Obese |
3.407800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.844010E-02 |
| Normal-vs-Age(41-60Yrs) |
1.790360E-04 |
| Normal-vs-Age(61-80Yrs) |
3.855400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.932000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.468000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.444000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.477230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.818000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.081400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.500800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76879999980173E-07 |
| Normal-VS-Type2 PRCC |
6.852400E-01 |
| Normal-VS-KIRP CIMP |
2.846400E-02 |
| Normal-VS-Unclassified PRCC |
2.425900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.161400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.934200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.753000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.041600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.854400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.043600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.559200E-01 |
| Normal-vs-N1 |
7.543600E-03 |
| Normal-vs-N2 |
5.402800E-01 |
| N0-vs-N1 |
3.198400E-01 |
| N0-vs-N2 |
8.450600E-01 |
| N1-vs-N2 |
4.048000E-01 |
|
|
